Semaglutide—sold as Ozempic for diabetes—has become one of the most widely prescribed drugs in recent years. As millions of people have started GLP-1 therapy, a side effect that gets far less attention than nausea or GI upset has been showing up in dermatology clinics and patient forums alike: hair shedding. It’s been nicknamed “Ozempic hair,” but the most commonly proposed explanation is telogen effluvium, and it’s worth understanding both what’s actually happening and how solid the evidence behind it is.
DOES OZEMPIC CAUSE HAIR LOSS?
Hair loss isn’t listed as an official side effect in Ozempic’s prescribing information. But that doesn’t mean it’s insignificant to the medication—it means large-scale trial data hasn’t flagged it as a clearly attributable adverse event. But the picture gets more interesting once you look past the label.
In clinical trials of Wegovy (the higher-dose semaglutide formulation approved specifically for weight loss), hair loss was reported more frequently among adults receiving semaglutide versus adults receiving a placebo (approximately 3% and 1% respectively). Tirzepatide—a medication that activates both GLP-1 and GIP receptors—has been known for producing even faster weight loss than semaglutide. Relatively, clinical trials of Tirzepatide have shown a higher percentage of hair loss, up to 5.7% of participants at its highest doses.
Beyond the trials, a review of FDA adverse event reports found a consistent pattern of alopecia complaints tied to semaglutide, and while spontaneous reporting data can’t prove causation on its own, the consistency across independent sources adds weight to the idea that a real dilemma is at hand. A separate analysis presented at the European Academy of Dermatology and Venereology found meaningfully higher rates of both telogen effluvium and androgenetic alopecia among GLP-1 users compared to non-users. One dataset put semaglutide users at roughly 50% higher odds of reporting hair loss than people on other weight-loss drugs.
Although hair loss is not an official side effect, it is a signal that’s shown up consistently enough. Researchers—including a UCSF-affiliated dermatology group that previously published on the topic—are now calling for dedicated prospective studies to pin down parallels between GLP-1 therapy and hair loss and to identify who is most at risk.
WHY HAIR LOSS HAPPENS AFTER RAPID WEIGHT LOSS
Firstly, it’s important to understand what is happening biologically. This is the part that matters most, because it explains why hair loss is not so commonly associated with GLP-1 medication.
Scalp hair grows in a cycle: most follicles (roughly 80–90% at any given time) are in an active growth phase called anagen, which can last for years. A smaller share sits in telogen, a resting phase that lasts about three months before the hair actually sheds and a new one starts growing in its place.
When the body goes through a significant physical stressor—surgery, a high fever, severe illness, or rapid weight loss—an unusually large batch of follicles can be pushed out of anagen and into telogen all at once. Because telogen has a fixed length, hair loss doesn’t show up immediately. It presents itself as a wave of shedding roughly two to three months later. That lag is a big part of why people often don’t connect their hair loss to the medication. By the time it shows up, they’ve usually been on the drug for months and may not think to link the two.
Semaglutide and similar drugs work by suppressing appetite and slowing digestion, which can produce weight loss fast enough—and calorie intake low enough—to functionally act as that kind of bodily stressor, even without touching the hair follicle directly.
There’s likely a second mechanism to this, contributing to hair loss: nutrition. Eating substantially less food for months at a time can mean falling short on iron, zinc, vitamin D, protein, and biotin—all of which are independently linked to hair shedding when deficient. So someone on a GLP-1 medication may be dealing with two overlapping triggers at once: the stress response from a rapid weight change, and an actual nutrient shortfall from reduced intake.
HOW LONG DOES OZEMPIC HAIR LOSS LAST?
Telogen effluvium is, by nature, temporary and self-correcting. Once the underlying stressor eases or the body adjusts to its new baseline, follicles cycle back into active growth. Most reports suggest shedding tapers off within three to six months, with fuller regrowth typically visible by six to nine months, especially if any nutritional gaps are addressed along the way. Telogen effluvium is not generally associated with permanent hair loss. However, people who have a genetic predisposition to pattern baldness may find this process accelerates or “unmasks” such long-term conditions in which a different diagnosis is recommended and worth a dermatologist’s input.
HOW TO SUPPORT HAIR HEALTH WHILE TAKING GLP-1 MEDICATIONS
Because this is largely a systemic, indirect effect rather than direct damage to the follicle, the standard advice leans supportive rather than drastic:
Get labs checked before supplementing. Iron/ferritin, zinc, and vitamin D deficiencies are all plausible contributors and worth testing for rather than guessing at. Biotin supplements, in particular, are easy to reach for but can throw off certain thyroid lab results, so it’s worth doing this with a clinician rather than solo.
Watch protein intake specifically. Hair is structurally built from protein, and it’s easy to under-eat it even while technically eating “enough” calories on an appetite suppressant.
Be gentle with fragile hair. Hair that’s shedding more than usual also tends to break more easily. Minimizing tight hairstyles, gentle detangling, and limiting heat styling can reduce breakage while new hair growth recovers. A lightweight conditioning oil before heat styling—like Kazani® Intensive Hair & Scalp Oil, formulated with grapeseed and castor oils to coat and protect the strand—can significantly cut down on friction damage and breakage at exactly the moment hair needs that protection most.
Consider gentler cleansing. Sulfate-free shampoos tend to be less stripping on hair and scalp that are vulnerable from physiological stress. Ingredients like rosemary oil and caffeine—found in scalp-focused formulations, including Kazani® Revitalizing Shampoo and Kazani® Revitalizing Hair Mask—have shown promising early results in small studies looking at scalp circulation. Emerging research suggests that rosemary oil in particular has performed comparably to low-dose minoxidil, making it a reasonable, low-risk addition to a scalp-care routine during this window.
Don’t discount stress and sleep. Psychological stress is its own independent trigger for telogen effluvium, so general stress management isn’t just a wellness platitude here — it’s a plausible contributing variable.
Know when to get it checked out. Patchy (rather than all-over) hair loss, scalp redness, itching or scarring, shedding that drags on past nine to twelve months, or shedding severe enough that the scalp becomes visible are all reasons to see a dermatologist. Those patterns point toward something other than typical telogen effluvium and are worth getting evaluated properly.
The best approach pairs both sides of the equation: correcting any nutritional gaps with your doctor, and giving hair and scalp genuinely good daily care while that process plays out. A consistent routine—like Kazani® Hair Care Bundle, which combines the Intensive Hair and Scalp Oil, Revitalizing Hair Shampoo, and Revitalizing Hair Mask into one system—gives hair the steady, nourishing environment it needs to come out of this stretch thriving, looking and feeling its best.
THE BIGGER PICTURE
Semaglutide doesn’t appear to attack hair follicles directly. What it does very effectively is produce fast, substantial weight loss—and that speed, combined with the nutritional complication of eating less for months, is enough to trigger a well-understood, self-limited shedding response in a meaningful minority of patients. While research on this connection is still evolving, current evidence suggests that hair loss is related to the physiological effects of rapid weight change, often with the combination of low nutritional intake, associated with GLP-1 therapy. The biological mechanism that underlies telogen effluvium is well established and offers a strong explanation for the observations and connections made. As additional studies become available, our understanding of the commonality of hair loss with GLP-1 users and what users are more susceptible to the loss becomes clearer.
For most individuals, such hair loss is temporary and resolves as the hair growth cycle returns to normal over several months. While recovering, the most effective strategies include ensuring and maintaining adequate protein and nutrient intake, handling fragile hair gently to minimize breakage, and consulting a dermatologist or healthcare provider if the loss becomes severe and persists beyond the typical timeframe for telogen effluvium.
FREQUENTLY ASKED QUESTIONS ABOUT OZEMPIC HAIR LOSS
Q: I started Ozempic three months ago and now my hair is falling out—is the medication causing it?
A: Hair shedding that begins two to three months after starting Ozempic is often linked to telogen effluvium, a temporary condition triggered by rapid weight loss, lower calorie intake, and nutritional changes. Experts believe the shedding is usually caused by the body’s response to these changes rather than direct damage from semaglutide itself.
Q: Is hair loss from Ozempic permanent?
A: For most people, no. Hair loss related to telogen effluvium is generally temporary and improves once the body adapts to weight loss and nutritional deficiencies are corrected.
Q: How long does Ozempic hair loss last?
A: Most people notice shedding slows within three to six months, while fuller regrowth may take six to nine months. Recovery depends on factors like nutrition, stress levels, and underlying hair conditions.
Q: Can Ozempic reveal or accelerate genetic hair loss?
A: Temporary shedding caused by weight loss can sometimes “unmask” androgenetic alopecia, making pre-existing thinning more noticeable. If hair loss persists beyond the typical recovery window of telogen effluvium, a dermatologist can help determine whether another condition is involved.
Q: What nutrients should I monitor while taking Ozempic to support healthy hair growth?
A: Healthcare providers commonly recommend checking protein intake as well as iron, ferritin, zinc, vitamin D, and other nutritional markers. Correcting deficiencies may help support recovery as the hair growth cycle returns to normal.
Q: What is the best hair-care routine if you’re experiencing shedding while taking Ozempic?
A: A supportive routine should focus on reducing breakage and protecting fragile hair. Gentle cleansing, minimizing heat styling, avoiding tight hairstyles, and using nourishing scalp products can help. Products like Kazani® Revitalizing Shampoo, Kazani® Revitalizing Hair Mask, and Kazani® Intensive Hair & Scalp Oil are designed to hydrate and protect hair, which comes in handy as the body adjusts to sudden weight changes.
Q: What ingredients should you look for in hair-care products if you’re experiencing Ozempic-related hair loss?
A: People dealing with temporary shedding often look for sulfate-free formulas and scalp-supporting ingredients such as rosemary oil, caffeine, and moisturizing plant oils. Kazani® Revitalizing Shampoo utilizes a combination of these sought out ingredients, providing great support and nourishment for hair. While these ingredients do not stop telogen effluvium, they can help improve hair texture and reduce breakage during recovery.
Q: Why do some people experience hair loss on GLP-1 medications while others don’t?
A: Not everyone taking GLP-1 medications, such as Ozempic or Wegovy, experiences hair loss. Factors like rapid weight loss, low protein intake, nutrient deficiencies, genetics, and stress can all increase the risk of temporary shedding.
Q: How do I stop shedding while taking GLP-1 medications?
A: You may not be able to stop shedding immediately, but there are several ways to support your hair while your body adjusts to GLP-1 treatment:
- Prioritize protein at every meal
- Ask your doctor to check iron, ferritin, zinc, and vitamin D levels
- Avoid crash dieting or extremely rapid weight loss
- Limit heat styling and tight hairstyles
- Get enough sleep and manage stress
- Use products that reduce breakage and keep hair hydrated
A consistent routine can make a meaningful difference. The Kazani® Hair Care Bundle—which combines Kazani® Intensive Hair & Scalp Oil, Kazani® Revitalizing Shampoo, and Kazani® Revitalizing Hair Mask—is designed to nourish the scalp and protect fragile strands while the hair growth cycle returns to normal.
Q: When should I see a dermatologist for hair loss on Ozempic?
A: You should speak with a dermatologist if:
- Hair loss is patchy instead of diffuse
- Your scalp becomes red, itchy, or irritated
- Shedding lasts longer than nine to twelve months
- You can see your scalp through thinning hair
- Hair loss becomes sudden or severe
These symptoms may indicate something other than typical telogen effluvium.
SHOP NOW.
SOURCES
Almohanna, H. M., Ahmed, A. A., Tsatalis, J. P., & Tosti, A. (2019). The role of vitamins and minerals in hair loss: A review. Dermatology and Therapy, 9, 51–70.
Harrison, S., & Sinclair, R. (2002). Telogen effluvium. Clinical and Experimental Dermatology, 27(5), 389–395.
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387, 205–216.
Paus, R., & Cotsarelis, G. (1999). The biology of hair follicles. New England Journal of Medicine, 341, 491–497.
Rojas Lopez, R. F., Lynett Barrera, D., Amaya Muñoz, M. C., & Saavedra Diaz, M. P. (2025). Alopecia as an emerging adverse effect associated with glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss: A scoping review. Cureus, 17(8), e90021.
Panahi, Y., Taghizadeh, M., Marzony, E. T., & Sahebkar, A. (2015). Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: Randomized comparative trial. SKINmed, 13(1), 15–21.
